Skip to content

CorMedix CRMD Total debt

Discontinued — last reported Q4 '25

Total debt at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$821.56M+0.5%
ITG
Integer HoldingsITGR
$1.38B+2.0%
IAR
Integra LifeSciencesIART
$1.98B+3.2%
MiMedx Group logo
MiMedx GroupMDXG
$17.59M-5.7%
Pfizer logo
PfizerPFE
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Plus components not separately reported this period.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's total debt?
CorMedix (CRMD) reported total debt of $4.29M in Q4 2025.
How has CorMedix's total debt changed year-over-year?
CorMedix's total debt increased by 729.4% year-over-year, from $517.01K to $4.29M.
What is the long-term trend for CorMedix's total debt?
Over 5 years (2020 to 2025), CorMedix's total debt has grown at a 32.9% compound annual growth rate (CAGR), from $1.03M to $4.29M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.